Clinical Trials on Neuroendocrine Tumor
Total 16990 results
-
Ochsner Health SystemMerck Sharp & Dohme LLCWithdrawnNeuroendocrine Carcinoma | Large Cell Neuroendocrine Carcinoma of the Lung | High Grade Neuroendocrine Carcinoma, Any SiteUnited States
-
Peking Union Medical College HospitalRecruitingLymphoma | Thymic Epithelial Tumor | Teratoma | Schwannoma | Germ Cell Tumor | Thymic Cyst | Retrosternal GoitreChina
-
Shaheen ShaguftaNational Cancer Institute (NCI)CompletedRecurrent Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Gastrinoma | Glucagonoma | Insulinoma | Pancreatic Polypeptide Tumor | Recurrent Islet Cell Carcinoma | SomatostatinomaUnited States
-
AstraZenecaCompletedRefractory Solid Tumors | Cancer TumorUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)WithdrawnGastrointestinal Carcinoid Tumor | Islet Cell Carcinoma
-
Fujian Maternity and Child Health HospitalRecruitingCervical Cancer | Neuroendocrine Neoplasm | Cervical Lesion | Women | ChinaChina
-
Sahlgrenska University Hospital, SwedenUnknownPancreatic Cyst | Pancreatic Neuroendocrine Carcinoma | Pancreatic Pseudocyst | Pancreatic Serous Cystadenoma | Pancreatic Mucinous Cystadenoma | Pancreatic Cystadenocarcinoma | Pancreatic Intraductal Papillary-Mucinous Neoplasm | Solid Pseudopapillary Tumor of the Pancreas
-
Centre Leon BerardGroupe Français de Pneumo-CancérologieNot yet recruitingLarge Cell Neuroendocrine Carcinoma of the LungFrance
-
Fudan UniversityNot yet recruitingPancreatic Neuroendocrine NeoplasmChina
-
Peking UniversityRecruitingNeuroendocrine Carcinoma of the BladderChina
-
Oncology Center of Biochemical Education And ResearchCompletedLarge Cell Neuroendocrine Carcinoma of the LungGreece
-
Technische Universität DresdenRoche Pharma AGRecruitingLarge Cell Neuroendocrine Carcinoma of the LungGermany
-
Novartis PharmaceuticalsCompletedWell-differentiated Non-functional NET of Thoracic Origin | Well-differentiated Non-functional NET of Gastrointestinal Origin | Well-differentiated Non-functional NET of Pancreatic Origin | Poorly-differentiated Gastroenteropancreatic Neuroendocrine CarcinomaUnited States, Italy, Spain, Japan, Belgium, Netherlands, Germany, France, Canada, Austria, United Kingdom, Australia
-
Novartis PharmaceuticalsCompletedNeuroendocrine Carcinoma of the Lung and ThymusItaly, United Kingdom, Netherlands, Spain, Germany, France, Greece, Denmark, Sweden
-
National Cancer Institute (NCI)RecruitingStage IV Prostate Cancer AJCC v8 | Metastatic Prostate Small Cell Neuroendocrine Carcinoma | Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation | Metastatic Prostate Neuroendocrine CarcinomaUnited States
-
Columbia UniversityCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLung Cancer | Islet Cell Tumor | Gastrointestinal Carcinoid Tumor | Neoplastic SyndromeUnited States
-
Asan Medical CenterNovartisUnknownNon Functioning Pancreatic Endocrine Tumor
-
Yale UniversityNational Cancer Institute (NCI)TerminatedDoxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine TumorsMetastatic Cancer | Islet Cell Tumor | Gastrointestinal Carcinoid TumorUnited States
-
Grupo Espanol de Tumores NeuroendocrinosCompletedNeuroendocrine Tumors | Neuroendocrine Neoplasm of LungSpain
-
Assistance Publique - Hôpitaux de ParisLigue contre le cancer, France; Imagine InstituteNot yet recruitingPelvic Tumor | Retroperitoneal TumorFrance
-
Duke UniversityNational Cancer Institute (NCI)CompletedMonoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain TumorsBrain and Central Nervous System Tumors | Metastatic Cancer | Melanoma (Skin)United States
-
Vancouver Coastal HealthUnknownNeuroblastoma | Pheochromocytoma | Paraganglioma | Medullary Thyroid Carcinoma | Carcinoid TumorsCanada
-
National Cancer Institute (NCI)RecruitingMalignant Solid Neoplasm | Rhabdoid Tumor | Refractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Rhabdoid Tumor | Refractory Rhabdoid Tumor | Epithelioid Sarcoma | Kidney Medullary Carcinoma | Atypical Teratoid/Rhabdoid Tumor | Poorly Differentiated Chordoma | Recurrent Atypical... and other conditionsUnited States, Australia, Canada
-
TuHURA Biosciences, Inc.Dana-Farber Cancer Institute; University of Southern California; H. Lee Moffitt... and other collaboratorsActive, not recruitingMerkel Cell Carcinoma | Cutaneous Squamous Cell Carcinoma | Non-Melanoma Skin CancersUnited States
-
University Hospital, Basel, SwitzerlandNot yet recruitingNeuroendocrine TumorsSwitzerland
-
Asian Institute of Gastroenterology, IndiaRecruiting
-
Peking Union Medical College HospitalRecruiting
-
Molecular Targeting Technologies, Inc.ClinSmartRecruitingNeuroendocrine TumorsUnited States
-
University of AlbertaRecruiting
-
Imperial College LondonAdvanced Accelerator Applications International SARecruiting
-
Peter MacCallum Cancer Centre, AustraliaRecruitingNeuroendocrine TumorsAustralia
-
First Affiliated Hospital of Fujian Medical UniversityPeking Union Medical College HospitalRecruiting
-
Ascentage Pharma Group Inc.RecruitingNeuroendocrine TumorsChina
-
University of Michigan Rogel Cancer CenterRecruitingNeuroendocrine TumorsUnited States
-
University Hospital, BrestRecruitingNeuroendocrine TumorsFrance
-
Radiomedix, Inc.Orano Med LLCActive, not recruitingNeuroendocrine TumorsUnited States
-
HutchmedNo longer available
-
Société Française d'Endoscopie DigestiveActive, not recruitingNeuroendocrine TumorsFrance, Belgium
-
University Health Network, TorontoCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedNeuroendocrine TumorsUnited States
-
Lowell Anthony, MDTerSera Therapeutics LLCTerminated
-
Radiomedix, Inc.CompletedNeuroendocrine TumorsUnited States
-
Rigshospitalet, DenmarkCompletedNeuroendocrine TumorsDenmark
-
AC Camargo Cancer CenterWithdrawnNeuroendocrine TumorsBrazil
-
Centre Hospitalier Universitaire de BesanconCompleted
-
Institut Paoli-CalmettesCompletedNeuroendocrine Tumors
-
Novartis PharmaceuticalsCompletedDose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs)Neuroendocrine TumorsUnited States
-
Dr. Nayruz KnaanaSheba Medical CenterUnknown